This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature

Volume: 48, Issue: 01, Pages: 055 - 071
Published: Jun 15, 2021
Abstract
The term “lupus anticoagulant (LA)” identifies a form of antiphospholipid antibodies (aPLs) causing prolongation of clotting tests in a phospholipid concentration-dependent manner. LA is one of the laboratory criteria identified in patients with antiphospholipid (antibody) syndrome (APS). The presence of LA in patients with APS represents a significant risk factor for both thrombosis and pregnancy morbidity. There have been several reports of...
Paper Details
Title
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
Published Date
Jun 15, 2021
Volume
48
Issue
01
Pages
055 - 071
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.